Microparticles as autoadjuvants in the pathogenesis of SLE

Nature Reviews Rheumatology

Volumn 6, Issue 6, 2010, Pages 368-372

  Pisetsky, David S ^a   Lipsky, Peter E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Nature Reviews Rheumatology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIGEN; CYTOKINE; DNA; INTERFERON; NUCLEIC ACID; RNA; TOLL LIKE RECEPTOR;

ANTIBODY RESPONSE; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW; CELL DEATH; CELL FATE; CYTOKINE PRODUCTION; EXTRACELLULAR SPACE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; MEMBRANE MICROPARTICLE; MEMBRANE VESICLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; B-LYMPHOCYTES; CELL-DERIVED MICROPARTICLES; DNA; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; RNA; TOLL-LIKE RECEPTORS;

EID: 77953229826     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.66     Document Type: Review

References (45)

1. Ardoin, S. P. & Pisetsky, D. S. Developments in the scientific understanding of lupus. Arthritis Res. Ther. 10, 218 (2008).
2. Kirou, K. A. et al. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 52, 1491-1503 (2005).
3. Ronnblom, L., Eloranta, M. L. & Alm, G. V. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 54, 408-420 (2006).
4. Deane, J. A. & Bolland, S. Nucleic acid-sensing TLRs as modifiers of autoimmunity. J. Immunol. 177, 6573-6578 (2006).
5. Martin, D. A. & Elkon, K. B. Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll-like receptor 9-independent pathway. Arthritis Rheum. 54, 951-962 (2006).
6. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007).
7. Beyer, C. & Pisetsky, D. S. The role of microparticles in the pathogenesis of rheumatic diseases. Nat. Rev. Rheumatol. 6, 21-29 (2010).
8. Pisetsky, D. S. Immune activation by bacterial DNA: a new genetic code. Immunity 5, 303-310 (1996).
9. Krieg, A. M. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 6, 546-549 (1995).
10. Yasuda, K. et al. Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes. J. Immunol. 183, 3109-3117 (2009).
11. Xiao, T. Innate immune recognition of nucleic acids. Immunol. Res. 43, 98-108 (2009).
12. Vallin, H., Perers, A., Aim, G. V. & Ronnblom, L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J. Immunol. 163, 6306-6313 (1999).
13. Boule, M. W. et al. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199, 1631-1640 (2004).
14. Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487-496 (2007).
15. Yasuda, K. et al. Murine dendritic cell type IIFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J. Immunol. 178, 6876-6885 (2007).
16. Jiang, W., Reich, I. C. & Pisetsky, D. S. Mechanisms of activation of the RAW264.7 macrophage cell line by transfected mammalian DNA. Cell. Immunol. 229, 31-40 (2004).
17. Jiang, W. & Pisetsky, D. S. The induction of HMGB1 release from RAW 264.7 cells by transfected DNA. Mol. Immunol. 45, 2038-2044 (2008).
18. Marques, J. T. et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24, 559-565 (2006).
19. Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J. & Alnemri, E. S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509-515 (2009).
20. Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518 (2009).
21. Crow, Y J. & Rehwinkel, J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum. Mol. Gen. 18, R130-R136 (2009).
22. Halicka, H. D., Bedner, E. & Darzynkiewicz, Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp. Cell Res. 260, 248-256 (2000).
23. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A. & Ratajczak, M. Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495 (2006).
24. Piccin, A., Murphy, W. G. & Smith, O. P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 21, 157-171 (2007).
25. Hasselmann, D. O., Rappl, G., Tilgen, W. & Reinhold, U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin. Chem. 47, 1488-1489 (2001).
26. Ng, E. K. et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 48, 1212-1217 (2002).
27. Reich, C. F. & Pisetsky, D. S. The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp. Cell Res. 315, 760-768 (2009).
28. De Gregorio, E., D'Oro, U. & Wack, A. Immunology of TLR-independent vaccine adjuvants. Curr. Opin. Immunol. 21, 339-345 (2009).
29. Yurasov, S. et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201, 703-711 (2005).
30. Jacobi, A. M., Zhang, J., Mackay, M., Aranow, C. & Diamond, B. Phenotypic characterization of autoreactive B cells - checkpoints of B cell tolerance in patients with systemic lupus erythematosus. PLoS ONE 4, e5776 (2009).
31. Tussiwand, R., Bosco, N., Ceredig, R. & Rolink, A. G. Tolerance checkpoints in B-cell development: Johnny B good. Eur. J. Immunol. 39, 2317-2324 (2009).
32. Lee, J., Kuchen, S., Fischer, R., Chang, S. & Lipsky, P. E. Identification and characterization of a human CD5+ pre-naive B cell population. J. Immunol. 182, 4116-4126 (2009).
33. Alexander, T. et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Stood 113, 214-223 (2009).
34. Munoz, L. E. et al. SLE - a disease of clearance deficiency? Rheumatology (Oxford) 44, 1101-1107 (2005).
35. Ogden, C. A. & Elkon, K. B. Role of complement and other innate immune mechanisms in the removal of apoptotic cells. Curr. Dir. Autoimmun. 9, 120-142 (2006).
36. Schiller, M. et al. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ. 15, 183-191 (2007).
37. Carrasco, Y. R. & Batista, F. D. B cell recognition of membrane-bound antigen: an exquisite way of sensing ligands. Curr. Opin. Immunol. 18, 286-291 (2006).
38. Tolar, P., Sohn, H. W., Liu, W. & Pierce, S. K. The molecular assembly and organization of signaling active B-cell receptor oligomers. Immunol. Rev. 232, 34-52 (2009).
39. Gould, S. J., Booth, A. M. & Hildreth, J. E. The Trojan exosome hypothesis. Proc. Natl Acad. Sci. USA 100, 10592-10597 (2003).
40. Christensen, S. R. et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417-428 (2006).
41. Nickerson, K. M. et al. TLR9 regulates TLR7-and MyD88-dependent autoantibody production and disease in a murine model of lupus. J. Immunol. 184, 1840-1848 (2010).
42. Krauss, S. W. et al. Nuclear substructure reorganization during late-stage erythropoiesis is selective and does not involve caspase cleavage of major nuclear substructural proteins. Blood 106, 2200-2205 (2005).
43. Napirei, M. et al. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25, 177-181 (2000).
44. Jiang, N., Reich, C. F. & Pisetsky, D. S. Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells. Blood 102, 2243-2250 (2003).
45. Jungel, A. et al. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum. 56, 3564-3574 (2007).